Home > Boards > US OTC > Biotechs > Kasten Inc. (KAST)

As clearly annotated in each of the 2017

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
PhenixBleu Member Profile
 
Followed By 57
Posts 4,943
Boards Moderated 5
Alias Born 05/06/14
160x600 placeholder
PhenixBleu   Friday, 03/16/18 11:26:40 AM
Re: otclife post# 4369
Post # of 4411 
Quote:
As clearly annotated in each of the 2017 quarterly reports, the financials have been stated without fully merged and comprehensive legacy numbers from the DAKOTA Life Sciences merger. When completed, these numbers will reflect the extensive financial details related to years of pharmaceutical research and development by DAKOTA. It has been the Company goal to provide fully merged GAAP financials as the basis for our Annual Report, due for filing soon. Due to the lack of new capital formation in 2017, the accounting effort to achieve these fully merged comprehensive financials was delayed. Regardless, the rapid completion of a PCAOB audit, in a form suitable for possible up-listing of the stock in 2018, is well underway.


Quote:
Kasten, Inc.
Consolidated Financial Statement
September 30, 2017
Amended February 27, 2018
KASTEN, INC
STATEMENTS OF EARNINGS
(Unaudited and without full integration of merger financials pending H2 PCAOB audit



Links to filings, news, website are at top of iBox.

Quote:
Dakota has no financials on their website to reference.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist